Raymond James analyst Steven Seedhouse upgrades Viking Therapeutics (NASDAQ:VKTX) from Outperform to Strong Buy and raises the price target from $115 to $116.
Raymond James Upgrades Viking Therapeutics to Strong Buy, Raises Price Target to $116
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.